T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VRAY
2676
DELISTED
ViewRay, Inc.
VRAY
| $117K | ﹤0.01% |
26,033
+2,919
| +13% | +$12.7K |
|
2677
Aemetis
AMTX
$124M
| $116K | ﹤0.01% |
29,396
-8,811
| -23% | -$50.1K |
|
2678
RPC Inc
RES
$1.4B
| $116K | ﹤0.01% |
13,054
+1,540
| +13% | +$13.9K |
|
|
SUNW
2679
DELISTED
Sunworks, Inc.
SUNW
| $116K | ﹤0.01% |
73,400
+23,000
| +46% | +$51.6K |
|
2680
Praxis Precision Medicines
PRAX
$10.6B
| $114K | ﹤0.01% |
3,196
+822
| +35% | +$25.6K |
|
|
YELL
2681
DELISTED
Yellow Corporation Common Stock
YELL
| $114K | ﹤0.01% |
45,243
| – | – |
|
2682
Select Water Solutions
WTTR
$2.71B
| $113K | ﹤0.01% |
12,218
+1,143
| +10% | +$9.63K |
|
|
LICY
2683
DELISTED
Li-Cycle Holdings Corp.
LICY
| $113K | ﹤0.01% |
2,968
+98
| +3% | +$4.4K |
|
|
CANO
2684
DELISTED
Cano Health, Inc.
CANO
| $113K | ﹤0.01% |
822
-7,292
| -90% | -$2.47M |
|
|
AEVA
2685
Aeva Technologies
AEVA
$1.68B
| $112K | ﹤0.01% |
16,439
-7,308
| -31% | -$64K |
|
|
NPKI
2686
NPK International
NPKI
$1.18B
| $112K | ﹤0.01% |
26,948
-47,785
| -64% | -$175K |
|
|
ENG
2687
DELISTED
ENGlobal Corp
ENG
| $112K | ﹤0.01% |
18,250
-268
| -1% | -$2.08K |
|
|
VCSA
2688
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $112K | ﹤0.01% |
4,466
-6,167
| -58% | -$288K |
|
2689
Carvana
CVNA
$80.8B
| $111K | ﹤0.01% |
116,710
-97,951,955
| -100% | -$207M |
|
2690
FTC Solar
FTCI
$38.5M
| $111K | ﹤0.01% |
4,143
+1,660
| +67% | +$39.3K |
|
2691
Nordic American Tanker
NAT
$1.4B
| $110K | ﹤0.01% |
35,993
+3,679
| +11% | +$11.9K |
|
|
USX
2692
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $110K | ﹤0.01% |
61,000
| – | – |
|
2693
EVgo
EVGO
$503M
| $109K | ﹤0.01% |
24,493
+1,067
| +5% | +$6.9K |
|
2694
OneSpaWorld
OSW
$2.72B
| $109K | ﹤0.01% |
11,639
+1,359
| +13% | +$12.9K |
|
|
VLDR
2695
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
| $109K | ﹤0.01% |
147,640
+61,676
| +72% | +$58.3K |
|
2696
Aptevo Therapeutics
APVO
$5.34M
| – | – |
0
| – | – |
|
2697
Oscar Health
OSCR
$9.15B
| $107K | ﹤0.01% |
43,371
-90,735
| -68% | -$284K |
|
|
ASTR
2698
DELISTED
Astra Space, Inc. Class A Common Stock
ASTR
| $107K | ﹤0.01% |
16,462
+2,964
| +22% | +$23.3K |
|
|
AMRN
2699
Amarin Corp
AMRN
$298M
| $106K | ﹤0.01% |
4,387
| – | – |
|
2700
PharmaCyte Biotech
PMCB
$5.92M
| $106K | ﹤0.01% |
36,400
-10,600
| -23% | -$30.4K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.